Next 10 |
home / stock / masi / masi articles
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Apple Inc. (NASDAQ:AAPL) has appealed to a U.S. appeals court to reverse a ban on the import of certain Apple Watches. The ban was imposed fol...
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) an...
Monday, activist investor Quentin Koffey, the founder of Politan Capital Management, nominated two candidates for election to the Masimo Board...
Major U.S. index futures edged lower on Monday, reflecting the cautious mood from last week’s close. The tech sector could face add...
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NA...
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street exp...
Editor’s note: This story has been updated with additional information about patent filings hinting at new functional gestures for upcoming v...
Apple Inc. (NASDAQ:AAPL) has reportedly been exploring the integration of a diverse range of sensors into its Apple Watch, with a focus on non...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024. The conference call to review the results will begin at 1:30 ...
Kiani’s Speech on Wednesday, at the 6 th Global Ministerial Summit on Patient Safety, Will Explore How AI-Based Medical Solutions Can Empower Clinicians and Improve Patient Safety Masimo (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a feature...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...